Patents by Inventor Hal V. Barron

Hal V. Barron has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment Method
    Publication number: 20080299117
    Abstract: The invention provides methods of treating autoimmune diseases using lower doses of anti-CD20 antibodies of 100 mg to 200 mg effective to deplete B cells in the patient.
    Type: Application
    Filed: May 21, 2008
    Publication date: December 4, 2008
    Inventors: Hal V. Barron, Andrew C. Chan, Daniel Combs, Wolfgang Dummer, Paul J. Fielder, Gwendolyn Fyfe
  • Method for treating occlusive peripheral vascular disease and coronary disease
    Patent number: 6440947
    Abstract: Compositions and methods for treatment of occlusive peripheral vascular disease and coronary disease are disclosed. The compositions and methods allow treatment of diseases associated with occlusion of coronary vessels, for example, by promoting growth of new blood vessels, i.e., angiogenesis and/or by recruitment of collaterals. The methods involve the co-administration of an adenosine A2 receptor agonist, e.g., adenosine, and heparin and/or a heparin-like substance over a period of several days. In particular, this invention is applicable to improving collateral coronary circulation in patients suffering from myocardial infarction.
    Type: Grant
    Filed: October 7, 1998
    Date of Patent: August 27, 2002
    Assignee: The Regents of the University of California
    Inventors: Hal V. Barron, Elias Botvinick
  • Method for promoting angiogenesis using heparin and adenosine
    Patent number: 5972903
    Abstract: This invention relates to a method of promoting growth of new blood vessels, i.e., angiogenesis, by coadministration of an adenosine receptor agonist, e.g., adenosine, and heparin over a period of several days. In particular, this invention is applicable to promoting angiogenesis to improve collateral coronary circulation in patients suffering from myocardial infarction.
    Type: Grant
    Filed: October 7, 1997
    Date of Patent: October 26, 1999
    Assignee: Regents of the University of California Corporation
    Inventors: Hal V. Barron, Elias Botvinick